BioSpace News Archive

Atea Pharmaceuticals, Inc. announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea Pharmaceuticals, will participate in and present a business update at the Jefferies London Healthcare Conference on Tuesday, November 15 at 5:00 p.m. GMT / 12:00 p.m. ET.

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today reported financial results for the third quarter ended September 30, 2022 and provided a corporate update.

POXEL SA provided a corporate update and announced its cash position and revenue for the third quarter and the nine months ended September 30, 2022.

Cold Spring Harbor Laboratory announced that preprint servers bioRxiv and medRxiv have received renewed funding from the Chan Zuckerberg Initiative.

Timber Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, announced that it will effect a 1-for-50 reverse stock split of its outstanding common stock.

Sentynl Therapeutics, Inc. (“Sentynl”) a US-based biopharmaceutical company focused on bringing innovative therapies to patients living with rare disease, joins the global Menkes disease community including the Menkes Foundation (“Menkes Foundation”) in recognizing the month of November as Menkes Disease Awareness Month.

The global Ophthalmic Drugs market size is expected to be worth around US$ 70.5 billion by 2030, according to a new report by Vision Research Reports.

The global MiRNA Sequencing And Assay market size is expected to be worth around US$ 600.8 Mn by 2030, according to a new report by Vision Research Reports

The global huntington’s disease treatment market size is expected to be worth around US$ 1.7 billion by 2030, according to a new report by Vision Research Reports.

Galapagos NV will present new dataon filgotinibat the American College of Rheumatology Convergence 2022 meetingtaking place in Philadelphia, Pennsylvania from 10-14 November 2022.